Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any injection therapy, changing your medication routine, or if you have any health concerns.

Tirzepatide is the active ingredient in Mounjaro and Zepbound, and compounded versions have been available through Australian prescribers and compounding pharmacies. Like semaglutide, tirzepatide is a once-weekly subcutaneous (the layer of fat just below the skin) injection used for type 2 diabetes management and weight loss. If you are new to injectable medications, the thought of self-injecting can feel overwhelming, but the process is straightforward once you understand the steps.

This guide covers how to inject tirzepatide at home using an insulin syringe, what supplies you need, correct injection technique, and common questions about dosing and side effects.

Tirzepatide injection supplies including insulin syringe, medication vial, and alcohol wipe — Everything you need for a tirzepatide injection: insulin syringe, medication vial, and alcohol wipe.

A disposable injectable medication pen with a single-use pen needle attached and the protective cap removed, lying horizontally on a clean background

1. What Is Tirzepatide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist. It works on two gut hormone pathways simultaneously, which distinguishes it from semaglutide (which targets only GLP-1). In clinical trials, tirzepatide demonstrated significant weight loss outcomes and improvements in blood sugar control.

In Australia, brand-name tirzepatide (Mounjaro) is TGA-approved for type 2 diabetes and is available via prescription.

Do not use tirzepatide if you or a family member have: medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN2), or a history of pancreatitis (inflammation of the pancreas, a rare but serious side effect).

Caution is needed if you have: gastroparesis or severe gastrointestinal disease, gallbladder disease, kidney disease, pregnancy or breastfeeding. Discuss these with your prescriber before starting.

Since October 2024, the TGA has restricted pharmacy compounding of GLP-1 receptor agonists (including tirzepatide and semaglutide) except under specific individualised prescribing circumstances. Most patients will receive branded Mounjaro from a pharmacy. If your prescriber has arranged a compounded product, it should be from a compliant compounding pharmacy working within current TGA guidelines.

2. Pen Device vs Compounded Vial

There are two ways you may receive tirzepatide:

Pre-filled pen (Mounjaro KwikPen)

The branded pen device comes pre-loaded with a single dose. You attach a pen needle, select your dose, press the button, and the device handles the injection. No drawing or measuring required. Follow the manufacturer's instructions for use provided with the pen.

Compounded vial

If your prescriber has arranged a compounded tirzepatide product, it comes in a multi-dose vial. You draw your dose manually using an insulin syringe, which gives you control over exact dosing. This is the focus of the technique section of this guide.

3. What You Need

Insulin syringe: A 1ml insulin syringe with 31G 6mm needle is the standard choice. The 31G needle is extremely fine, and the 6mm length is ideal for subcutaneous injection in the abdomen. If your dose is consistently under 0.5ml, a 0.5ml syringe gives you finer graduation marks for more precise measurement.
Alcohol wipes: 70% isopropyl alcohol wipes. One for the vial stopper, one for the injection site.
Your tirzepatide: Stored in the refrigerator as directed by your prescriber or pharmacy.
Sharps container: For used syringe disposal. Available from pharmacies or council programs. See our disposal guide.

If you are new to self-injection, the GLP-1 Starter Kit includes 10 insulin syringes and 20 alcohol wipes, enough for 10 weekly injections.

4. Step-by-Step Injection Guide

This covers the process for injecting from a vial using an insulin syringe.

Step 1: Prepare your workspace

Wash your hands thoroughly with soap and water. Set out your syringe, alcohol wipes, vial, and sharps container on a clean surface. Having everything within reach before you start makes the process smoother.

Step 2: Prepare the vial

Remove the vial from the refrigerator and let it sit for 5-10 minutes to approach room temperature. Cold solution can cause more discomfort and stinging during injection. Wipe the rubber stopper with an alcohol wipe and let it air-dry for 10 seconds.

Step 3: Draw your dose

Pull the syringe plunger back to draw in air equal to your dose volume. This helps equalise pressure inside the vial. Insert the needle through the rubber stopper, push the air in, then invert the vial and slowly draw your prescribed dose. Tap the syringe gently to move any air bubbles to the top, then push them back into the vial. Re-check your dose volume and withdraw the needle from the vial.

You can work out the volume with our dose volume calculator.

If you are unfamiliar with reading syringe markings, see our How to Read an Insulin Syringe guide.

Step 4: Prepare the injection site

Choose your injection site (see next section). Wipe the area with a fresh alcohol wipe. Let it air-dry completely before injecting. Injecting through wet alcohol stings.

Step 5: Inject

Gently pinch a fold of skin at the injection site. Hold the syringe like a dart and insert the needle at a 90-degree angle with a smooth, confident motion. Once inserted, release the pinch. Push the plunger down slowly and steadily over 5-10 seconds.

Step 6: Hold and withdraw

After the plunger reaches the bottom, hold the needle in place for 5-10 seconds to allow the solution to disperse. Withdraw the needle smoothly at the same angle. Press a clean wipe gently on the site. Do not rub.

Step 7: Dispose

Drop the used syringe directly into your sharps container. Do not recap the needle.

5. Best Injection Sites for Tirzepatide

Tirzepatide is a subcutaneous injection. The three recommended sites are:

Abdomen

The most popular site. Inject into the lower abdomen, at least 5cm (2 inches) from the navel in all directions. Avoid the waistline and any scarred areas. The abdomen typically has a consistent fat layer and is easy to reach.

Upper outer thigh

The front and outer area of the upper thigh, between the knee and hip. This site is particularly good for people who find the abdomen sensitive or who want to rotate away from it.

Upper arm (back)

The fatty area on the back of the upper arm. This site is easier if someone else is administering the injection, as it can be difficult to reach on your own. It is a legitimate site but less commonly used for self-injection.

Upper outer buttock

The upper outer quadrant of the buttock works well for people whose abdomen and thighs do not carry enough subcutaneous fat for a comfortable injection — particularly lean men. The area has reliable fat coverage and stays hidden under clothing. Reach across with the opposite hand or use a mirror to see the site clearly.

Rotate your injection site each week. Do not inject in the same spot two weeks in a row. Rotate between left and right sides, and between different body areas. This prevents tissue damage and ensures consistent absorption. For a deeper dive on rotation strategies, see our injection technique guide.

6. Storage and Handling

Refrigerate at 2-8°C. Store in the refrigerator, not the freezer. Do not freeze.
Protect from light. Keep the vial in its packaging or in a dark area of the refrigerator.
Room temperature window: Most formulations can be at room temperature for short periods (during preparation and injection). Do not leave the vial out for extended periods.
Check expiry: Follow the use-by date provided by your prescriber or pharmacy.
Inspect before use: The solution should be clear and colourless. Do not use if it is cloudy, discoloured, or contains particles.

7. Managing Common Side Effects

The most common side effects of tirzepatide are gastrointestinal and typically improve over time:

Nausea

The most frequently reported side effect, especially during dose escalation. Eating smaller, more frequent meals can help. Avoid fatty, rich, or heavily seasoned foods in the hours after injection. Most people find nausea decreases significantly after the first few weeks at each new dose level.

Seek urgent medical care if you develop severe abdominal pain that radiates to your back, persistent vomiting, or inability to keep fluids down - these can be signs of pancreatitis.

Reduced appetite

This is, in part, the intended effect for weight management. Ensure you are still eating adequate protein and nutrition even when appetite is low. Protein shakes or small, protein-rich snacks can help maintain nutrition on low-appetite days.

Injection site reactions

Mild redness, swelling, or itching at the injection site is common and typically resolves within a day or two. Rotating your injection site and ensuring the alcohol wipe is fully dry before injection reduces the chance of irritation.

Constipation or diarrhoea

GI changes are common as your body adjusts. Staying hydrated and maintaining fibre intake helps. If symptoms are persistent or severe, consult your prescriber.

Gallbladder problems

Gallbladder problems (including gallstones and inflammation) have been reported with GLP-1 receptor agonists. Contact your doctor if you develop upper right abdominal pain, yellowing of the skin or eyes, or fever.

Hypoglycaemia (low blood sugar)

Tirzepatide itself rarely causes hypoglycaemia, but combining it with insulin or sulfonylureas significantly increases the risk. If you take those medications, monitor blood sugar closely and discuss dose adjustments with your prescriber.

Important: If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction (difficulty breathing, severe rash, swelling of the face or throat), seek immediate medical attention.

When to call your prescriber

Most injections go smoothly - a small drop of blood or a brief sting are normal. The list below covers things that aren't normal and warrant a phone call to your prescriber:

Redness, warmth or pus at the injection site that develops over 24-72 hours
A hard lump that doesn't go away after a week, or one that's hot and tender
Fever, chills or feeling unwell after an injection
Any rash, hives or itching at or beyond the injection site (possible allergic reaction)
Signs of a severe allergic reaction - swelling of face or throat, difficulty breathing - call 000 immediately
You realise you injected from a vial that had been left out, was cloudy or contained particles

Frequently Asked Questions

What size needle for tirzepatide injection?

For tirzepatide from a vial, a 29G-31G insulin needle with 6mm length is standard. A 1ml 31G 6mm insulin syringe is the most common choice. For the Mounjaro pen device, the pen needles come separately and are typically 31G or 32G. See our Needle Gauge Guide for a full breakdown.

Can I use the same syringe as semaglutide?

Yes. If you are injecting from a vial, you use the same type of insulin syringe as you would for compounded semaglutide. The injection technique is identical. A 1ml 31G 6mm insulin syringe works for both medications.

What day should I inject tirzepatide?

Tirzepatide is a once-weekly injection. Choose a consistent day of the week that works for your routine and stick with it. If you need to change your injection day, your prescriber can advise on how to adjust. It does not need to be the same time of day each week, but consistency helps you remember.

What happens if I miss a dose?

If you miss a dose, refer to the missed-dose instructions provided by your prescriber or on your product information leaflet - timing rules differ between products. Do not double up without explicit guidance.

Is tirzepatide the same as semaglutide?

No. While both are injectable GLP-1 receptor agonists used for diabetes and weight management, tirzepatide is a dual-action GIP/GLP-1 agonist (it targets two pathways), whereas semaglutide targets only GLP-1. They have different dosing schedules, dose escalation protocols, and clinical profiles. Your doctor will determine which is appropriate for you.

Can I buy tirzepatide injection supplies without a prescription in Australia?

Yes. The injection supplies (syringes, needles, alcohol wipes) do not require a prescription in Australia. The tirzepatide medication itself requires a prescription. You can purchase all injection supplies online and have them delivered to your door.